Related references
Note: Only part of the references are listed.Hospital admission patterns of adult patients with complicated urinary tract infections who present to the hospital by disease acuity and comorbid conditions: How many admissions are potentially avoidable?
Thomas P. Lodise et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2021)
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study
Marya D. Zilberberg et al.
BMC INFECTIOUS DISEASES (2021)
Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection (vol 6, ofz446, 2019)
Joseph J. Carreno et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in US Hospitals, 2013 to 2018
Marya D. Zilberberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Assessment of the Accuracy of Using ICD-9 Diagnosis Codes to Identify Pneumonia Etiology in Patients Hospitalized With Pneumonia
Thomas L. Higgins et al.
JAMA NETWORK OPEN (2020)
Epidemiology, definition and treatment of complicated urinary tract infections
Florian M. E. Wagenlehner et al.
NATURE REVIEWS UROLOGY (2020)
Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study
Laura Vallejo-Torres et al.
BMJ OPEN (2018)
Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections
Aina Gomila et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Catheter-Associated Urinary Tract Infection: Utility of the ICD-10 Metric as a Surrogate for the National Healthcare Safety Network (NHSN) Surveillance Metric
Alexandre R. Marra et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
Marya D. Zilberberg et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2017)
The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998-2011
Jacob E. Simmering et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
Marya D. Zilberberg et al.
BMC INFECTIOUS DISEASES (2017)
Share Paper
